KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to $194.6 million.

  • Opko Health's Cash from Investing Activities fell 21.44% to $194.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.3 million, marking a year-over-year increase of 48.35%. This contributed to the annual value of $352.2 million for FY2024, which is 2035.45% up from last year.
  • Latest data reveals that Opko Health reported Cash from Investing Activities of $194.6 million as of Q3 2025, which was up 6,968.31% from -$2.8 million recorded in Q2 2025.
  • Opko Health's Cash from Investing Activities' 5-year high stood at $247.8 million during Q3 2024, with a 5-year trough of -$8.8 million in Q2 2021.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$2.8 million (2025), whereas its average is $51.5 million.
  • As far as peak fluctuations go, Opko Health's Cash from Investing Activities crashed by 343.31% in 2022, and later spiked by 8,279.62% in 2024.
  • Opko Health's Cash from Investing Activities (Quarterly) stood at -$8.7 million in 2021, then climbed by 9.30% to -$7.9 million in 2022, then spiked by 81.99% to -$1.4 million in 2023, then soared by 8,279.62% to $116.0 million in 2024, then dropped by 21.44% to $194.6 million in 2025.
  • Its Cash from Investing Activities was $194.6 million in Q3 2025, compared to -$2.8 million in Q2 2025 and $40.5 million in Q1 2025.